Lymphoma Therapy
Recent findings from D. Machover and co-authors highlight research in lymphoma therapy
Published in Blood Weekly, March 25th, 2010
Research findings, 'Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma,' are discussed in a new report. According to recent research published in the journal Biomedicine & Pharmacotherapy, "We explored the addition of rituximab to high-dose cytarabine (ara-C), oxaliplatin (L-OHP), and dexamethasone [R-DHAOx], in resistant and relapsed patients with CD20-positive follicular non-Hodgkin's lymphoma. Twenty-two patients were included; they were treated previously with one to five chemotherapy regimens, including 13 patients who had also...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-03-25)
More Articles from Blood Weekly
- Tufts University, Health Sciences
Novel antitoxin strategy developed using 'tagged binding agents' - Wiley-Blackwell
US doctors sanction transplant criteria for liver cancer patients - Alpha-thalassemia
Research results from Chiang Mai University update knowledge of alpha-thalassemia - American Society of Hematology
Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism - Apoptosis
Studies from China Medical University in the area of apoptosis described - Biomedical Engineering
New biomedical engineering study results from H.Y. Sun et al described - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
